Atlas Venture Life Science Advisors, LLC Long-Term Concentrated

Name: Atlas Venture Life Science Advisors, LLC Q3 2024 13F Filing | 13F Explorer
Creator: Atlas Venture Life Science Advisors, LLC
Published: 2024-11-13

Location: Cambridge, MA

CIK: 0001917529 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 13, 2024

Total Value: $1.079B (100.0% shares, 0.0% debt)

Holdings (14)

DYN Dyne Therapeutics, Inc. 26.7%

Value $288M Shares 8,020,136 Est. Cost $13.82 Unrealized +188.0%

KYMR Kymera Therapeutics, Inc. 21.5%

Value $232M Shares 4,896,462 Est. Cost $58.25 Unrealized -24.2%

— Third Harmonic Bio, Inc. 13.7%

Value $148M Shares 10,907,859 Est. Cost $18.97 Unrealized —

IRON Disc Medicine, Inc. 11.4%

Value $123M Shares 2,509,456 Est. Cost $48.39 Unrealized -3.0%

QTTB Q32 Bio, Inc. 8.7%

Value $93.35M Shares 2,092,106 Est. Cost $13.78 Unrealized +166.7%

DAWN Day One Biopharmaceuticals, Inc. 8.3%

Value $89.57M Shares 6,430,257 Est. Cost $19.68 Unrealized -27.5%

KRRO Korro Bio, Inc. 3.5%

Value $38M Shares 1,137,149 Est. Cost $33.30 Unrealized +26.4%

— Generation Bio, Co. 1.9%

Value $20.45M Shares 8,279,484 Est. Cost $7.08 Unrealized —

— Vigil Neuroscience, Inc. 1.8%

Value $19.85M Shares 5,836,874 Est. Cost $7.03 Unrealized —

TECX Tectonic Therapeutics, Inc. 1.1%

Value $11.47M Shares 378,447 Est. Cost $15.77 Unrealized +15.9%

— Ikena Oncology, Inc. 0.8%

Value $8.681M Shares 5,018,178 Est. Cost $12.54 Unrealized —

— Aerovate Therapeutics, Inc. 0.3%

Value $3.76M Shares 1,799,232 Est. Cost $11.88 Unrealized —

DNTH Dianthus Therapeutics, Inc. 0.2%

Value $2.108M Shares 76,979 Est. Cost $12.62 Unrealized +120.8%

SPRO Spero Therapeutics, Inc. 0.1%

Value $540K Shares 402,885 Est. Cost $15.88 Unrealized -91.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
DYN	Dyne Therapeutics, Inc.	8,020,136	$288M	26.7%	$13.82	+188.0%	Common Stock	26818M108
KYMR	Kymera Therapeutics, Inc.	4,896,462	$232M	21.5%	$58.25	-24.2%	Common Stock	501575104
—	Third Harmonic Bio, Inc.	10,907,859	$148M	13.7%	$18.97	—	Common Stock	88427A107
IRON	Disc Medicine, Inc.	2,509,456	$123M	11.4%	$48.39	-3.0%	Common Stock	254604101
QTTB	Q32 Bio, Inc.	2,092,106	$93.35M	8.7%	$13.78	+166.7%	Common Stock	746964105
DAWN	Day One Biopharmaceuticals, Inc.	6,430,257	$89.57M	8.3%	$19.68	-27.5%	Common Stock	23954D109
KRRO	Korro Bio, Inc.	1,137,149	$38M	3.5%	$33.30	+26.4%	Common Stock	500946108
—	Generation Bio, Co.	8,279,484	$20.45M	1.9%	$7.08	—	Common Stock	37148K100
—	Vigil Neuroscience, Inc.	5,836,874	$19.85M	1.8%	$7.03	—	Common Stock	92673K108
TECX	Tectonic Therapeutics, Inc.	378,447	$11.47M	1.1%	$15.77	+15.9%	Common Stock	878972108
—	Ikena Oncology, Inc.	5,018,178	$8.681M	0.8%	$12.54	—	Common Stock	45175G108
—	Aerovate Therapeutics, Inc.	1,799,232	$3.76M	0.3%	$11.88	—	Common Stock	008064107
DNTH	Dianthus Therapeutics, Inc.	76,979	$2.108M	0.2%	$12.62	+120.8%	Common Stock	252828108
SPRO	Spero Therapeutics, Inc.	402,885	$540K	0.1%	$15.88	-91.6%	Common Stock	84833T103